Federated Hermes
ANRO icon

Federated Hermes’s Alto Neuroscience ANRO Stock Holding History

Federated Hermes’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.9K Sell
110
-544
-83% -$12.6K ﹤0.01% 1968
2026
Q1 		$14.7K Sell
654
-116
-15% -$2.15K ﹤0.01% 1814
2025
Q4 		$13.7K Sell
770
-2,577
-77% -$32.5K ﹤0.01% 1808
2025
Q3 		$13.5K Buy
3,347
+2,582
+338% +$8.56K ﹤0.01% 1852
2025
Q2 		$1.68K Buy
+765
New +$1.82K ﹤0.01% 1967
2024
Q4 		– Sell
-16,000
Closed -$183K – 2205
2024
Q3 		$183K Buy
16,000
+4,000
+33% +$49K ﹤0.01% 1496
2024
Q2 		$128K Buy
12,000
+3,000
+33% +$39K ﹤0.01% 1542
2024
Q1 		$138K Buy
+9,000
New +$141K ﹤0.01% 1545

Other funds holding ANRO

AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SSC
Spruce Street Capital New York $510M AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Federated Hermes's ANRO Position: Q2 2026 in Review

Federated Hermes reduced its Alto Neuroscience (ANRO) stake by 83% in Q2 2026, selling an estimated $12.6K and leaving 110 shares worth $2.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1968.

Federated Hermes first reported a position in ANRO in Q1 2024 and has held it in 8 quarters since. The position peaked at $183K in Q3 2024. 114 funds tracked by Wall St. Rank hold ANRO as of Q2 2026.

  • Federated Hermes held 110 shares of Alto Neuroscience worth $2.9K as of Q2 2026.
  • Federated Hermes sold 544 Alto Neuroscience shares in Q2 2026, an estimated $12.6K.
  • Alto Neuroscience made up ﹤0.01% of Federated Hermes's portfolio in Q2 2026, its #1968 holding.
  • Federated Hermes first reported a position in Alto Neuroscience in Q1 2024 and has held it in 8 quarters since.
  • Federated Hermes's Alto Neuroscience position peaked at $183K in Q3 2024.
  • 114 funds tracked by Wall St. Rank held Alto Neuroscience as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.